GlobeNewswire 03-11 Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments targeting a...
GlobeNewswire 2023-11-16 Raymond and its Solutions and Support Centers Continue Pledge to Giving Back, Supporting Local Commu...
GlobeNewswire 2023-11-09 Peyto Celebrates 25 Years With Q3 2023 Results
GlobeNewswire 2023-11-06 Hammerhead Energy Inc. Announces Record Financial and Operating Results for Third Quarter 2023 and a...
TeleTrader 2022-05-21 Russia says it destroyed western arms for Ukraine
GlobeNewswire 2022-03-09 Peyto Funds Flow Rebounds in 2021
GlobeNewswire 2021-12-14 Gurnick Academy Tablet Giveaway
GlobeNewswire 2021-12-09 Gurnick Academy of Medical Arts Receives Capps' School of the Year Award
GlobeNewswire 2021-11-23 Law Firm Launches Missions-Oriented Web Series
GlobeNewswire 2021-11-09 Peyto Reports Third Quarter 2021 Results, Reinstates Monthly Dividend
GlobeNewswire 2021-10-01 McKinsey Receives Best-in-Class Distinctions in the POI 2021 Enterprise Planning Vendor Panorama Rep...
GlobeNewswire 2021-09-23 Gurnick Academy to Launch Nuclear Medicine Program
GlobeNewswire 2021-09-02 ESE Acquisition Target, Digital Motorsports, Announces Multi-Year Deal with Rising F3 Star Jack Dooh...
Newsfile Corp 2021-08-12 Fossil Fuels Far From Extinct: Oil and Gas Companies See Record Revenues
GlobeNewswire 2021-08-11 Peyto Reports Second Quarter 2021 Results
GlobeNewswire 2021-05-12 Peyto Posts Strong Q1 2021 Profits
GlobeNewswire 2021-05-04 Jounce Therapeutics Reports First Quarter 2021 Financial Results
GlobeNewswire 2021-04-28 Jounce Therapeutics to Present Trial in Progress Posters on the Phase 1 INNATE and the Phase 2 SELEC...
GlobeNewswire 2021-04-27 Jounce Therapeutics to Announce First Quarter 2021 Financial Results and Host Conference Call on Tue...
GlobeNewswire 2021-04-13 Nouveau Monde Confirms Its Firm Commitment to Achieving Past, Present & Future Carbon Neutrality, by...
GlobeNewswire 2021-04-12 Jounce Therapeutics Appoints Dmitri Wiederschain, Ph.D., as Chief Scientific Officer
GlobeNewswire 2021-04-10 Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 American Asso...
GlobeNewswire 2021-03-12 Jounce Therapeutics Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
GlobeNewswire 2021-03-10 Jounce Therapeutics to Present Preclinical Data from JTX-8064 Program at the 2021 American Associati...
GlobeNewswire 2021-03-10 Jounce Therapeutics Announces Pricing of $56.25 Million Public Offering of Common Stock